Success Stories: Mapping the Human Genome with AI: EB2-NIW Approved for Computational Biologist Advancing Precision Medicine

Client’s Testimonial:

“Thank you for helping me put together a strong case for my EB-2 NIW application. You were incredibly professional and guided me through every step of the case preparation.”

On May 21^st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Computational Biologist in the Computational Biology (Approval Notice).

General Field: Computational Biology

Position at the Time of Case Filing: Computational Biologist

Approval Notice Date: May 21^st, 2025

Processing Time: 1 month, 11 days (Premium Processing Requested)

Case Summary:

We are thrilled to announce the EB2-NIW (National Interest Waiver) approval for an accomplished computational biologist whose pioneering work is revolutionizing how we understand the genetic architecture of complex diseases. This researcher has made significant contributions to genomic science through the integration of artificial intelligence, enabling more accurate identification of disease-causing DNA elements and supporting the development of precision diagnostics and therapies.

Uncovering the Genetic Code Behind Disease

This client’s research centers on the identification of functional DNA regulatory elements using machine learning, with direct applications to understanding the genetic basis of cancer, autoimmune diseases, and viral infections. His work employs deep learning models and high-throughput genomic datasets to uncover genetic variants that play key roles in disease manifestation.

A Research Portfolio with High Impact

The client has authored 2 peer-reviewed journal articles, 2 peer-reviewed conference papers, and 2 preprints, with 22 citations across his publications. His work has appeared in highly ranked journals, including Bioinformatics, recognized as a leading journal in computational biology, and has been cited by researchers conducting advanced studies in genomics, virus evolution, and chromatin segmentation.

He has also conducted at least 25 peer reviews for journals and conferences such as PLOS One, Bioinformatics, ISMB, and MLCB, establishing his authority in the field.

Strengthening the Nation’s Biomedical Infrastructure

One of the client’s notable projects introduced a next-generation sequencing platform for SARS-CoV-2 variant detection. In a letter of recommendation, a senior executive at a biotech firm described the strategic relevance of this work:

“His target-capture sequencing approach is enhancing national preparedness by offering more complete genomic data than traditional amplicon methods… His work strengthens pandemic response competence and exemplifies the importance of innovative diagnostic tools in computational biology”.

This method demonstrated greater genomic coverage compared to conventional techniques and was later cited in Nature Microbiology and Virus Research for its practical applications in viral surveillance and public health.

His recent efforts focus on annotating the human genome using chromatin state features across hundreds of cell types. By integrating epigenomic data with AI-driven segmentation, he has developed tools that advance our understanding of genome function, disease prediction, and personalized medicine.

Recognition and Funding

The client’s work has been supported by major institutions, all of which are known for supporting impactful scientific initiatives.

Rapid Approval Reflects National Significance

Filed on April 10, 2025, and approved on May 21, 2025, this EB2-NIW petition received swift adjudication. The success of this case rested on compelling documentation of the client’s technical expertise, innovative methodologies, and the broad utility of his research in advancing U.S. leadership in biomedical science.

We take pride in representing researchers whose work pushes the boundaries of what’s possible in science and medicine. This client’s journey from AI-powered genome annotation to public health innovations embodies the spirit of national interest, scientific excellence, and global collaboration. We’re proud to help bring such visionaries closer to realizing their goals in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.